Elevated levels of CD38+ CD8+ t cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up

Journal of Acquired Immune Deficiency Syndromes

Volumn 6, Issue 8, 1993, Pages 904-912

  Giorgi, Janis V ^a   Liu, Zhiyuan ^b   Hultin, Lance E ^a   Cumberland, William G ^b   Hennessey, Karen ^b   Detels, Roger ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD38+; CD8+; Conditional probability; Dual color immunophenotyping; Flow cytometry; HIV; Longitudinal cohort study; Prognosis; T lymphocyte

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; L SELECTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE COURSE; FLOW CYTOMETRY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PROGNOSIS; T LYMPHOCYTE SUBPOPULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD; ANTIGENS, CD57; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; COHORT STUDIES; FOLLOW-UP STUDIES; HIV INFECTIONS; HLA-DR ANTIGENS; HUMAN; L-SELECTIN; LEUKOCYTE COUNT; MALE; MULTICENTER STUDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS;

EID: 0027304957     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Taylor JMG, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 1989; 2:114-24.
2. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322:166-72.
3. Burcham J, Marmor M, Dubin N, et al. CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991; 5:365-72.
4. Chevret S, Roquin H, Ganne P, Lefrère J-J. Prognostic value of an elevated CD8 lymphocyte count in HIV infection. Results of a prospective study of 152 asymptomatic HIV-positive individuals. AIDS 1992; 6:1349-52.
5. + cells in HIV-related diseases. In: Janossy G, Autran B, Miedema F, eds. Immunodeficiency in HIV infection and AIDS. Basel: Karger, 1992:171-84.
6. Prince HE, Kleinman S, Czaplicki C, John J, Williams AE. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. J Acquir Immune Defic Syndr 1990; 3:525-30.
7. Giorgi JV. CD4 counts in relation to markers of immune activation. In: Janossy G, Autran B, Miedema F, eds. Immunodeficiency in HIV infection and AIDS. Basel: Karger, 1992:1-17.
8. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin Immunol Immunopathol 1989; 52:10-8.
9. Landay A, Ohlsson-Wilhelm B, Giorgi JV. Application of flow cytometry to the study of HIV infection. AIDS 1990; 4:479-97.
10. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-8.
11. Chmiel JS, Detels R, Kaslow RA, et al. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the multicenter AIDS cohort study. Am J Epidemiol 1987; 126:568-77.
12. Kansas GS, Engelman EG. Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressorinducer T cells of βcell differentiation in man. Eur J Immunol 1987; 17:453-7.
13. Phillips JH, Lanier LL. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol 1986; 136:1579-85.
14. + lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur J Immunol 1991; 21:737-41.
15. Funaro A, Spagnoli GC, Ausiello CM, et al. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol 1990; 145:2390-6.
16. Hercend T, Ritz J, Schlossman SF, Reinherz EL. Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. Hum Immunol 1981; 3:247-59.
17. Mittler RS, Rao PE, Talle MA, Look R, Goldstein G. Cell membrane perturbation of resting T cells and thymocytes causes display of activation antigens. J Exp Med 1983; 158:99-111.
18. Taylor J, Afrasiabi R, Fahey JL, Korns E, Weaver M, Mitsuyasu R. Prognostically significant classification of immune changes in AIDS with Kaposi’s sarcoma. Blood 1986; 67:666-71.
19. + cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993; 150:3070-9.
20. Giorgi JV, Nishanian PG, Schmid I, Hultin LE, Cheng H-L, Detels R. Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection. J Clin Immunol 1987; 7:140-50.
21. Centers for Disease Control. Revisions of the CDC surveillance definition for acquired immunodeficiency syndrome. MMWR 1987; 36:15-155.
22. Giorgi JV, Cheng H-L, Margolick JB, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. Clin Immunol Immunopathol 1990; 55:173-86.
23. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992; 90:376-82.
24. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34:187-220.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
26. Dixon WJ. BMDP statistical software manual. Los Angeles: University of California Press, 1988.
27. + cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol 1991; 11:345-55.
28. Kestens L, Vanham G, Gigase P, et al. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. AIDS 1992; 6:793-7.
29. + cells in human immunodeficiency virus type-1 infection. Clin Immunol Immunopathol 1992; 63:126-34.
30. World Health Organization. Acquired immunodeficiency syndrome (AIDS): interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990; 65:221-8.
31. + subsets: consequence on the CD4/CD8 ratio. Clin Exp Immunol 1991; 85:481-4.
32. + cells. J Immunol 1990; 144:2992-8.
33. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virusspecific cytotoxicity. Proc Natl Acad Sci USA 1990; 87:4818-22.
34. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990; 11:176-80.
35. Streuli M, Morimoto C, Schrieber M, Schlossman SF, Saito H. Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens. J Immunol 1988; 141:3910-4.
36. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T-suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J Immunol 1985; 135:1778-85.
37. Lewis DE, Puck JM, Babcock GF, Rich RR. Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J Infect Dis 1985; 151:555-9.
38. Stites DP, Moss AR, Bacchetti P, et al. Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco. Clin Immunol Immunopathol 1989; 52:96-103.